Sheaff Brock Investment Advisors, LLC - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 77 filers reported holding SYNTHETIC BIOLOGICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Sheaff Brock Investment Advisors, LLC ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q2 2018$24,000
-25.0%
100,0120.0%0.00%
-33.3%
Q1 2018$32,000
-37.3%
100,0120.0%0.00%
-57.1%
Q4 2017$51,000
-61.1%
100,012
-28.6%
0.01%
-58.8%
Q3 2017$131,000
+65.8%
140,0120.0%0.02%
+70.0%
Q2 2017$79,000
-3.7%
140,012
+7.7%
0.01%
-9.1%
Q1 2017$82,000
+7.9%
130,012
+30.0%
0.01%
+10.0%
Q4 2016$76,000
-49.0%
100,012
+15.7%
0.01%
-50.0%
Q3 2016$149,000
-4.5%
86,4490.0%0.02%0.0%
Q2 2016$156,000
-6.6%
86,449
+22.5%
0.02%
-4.8%
Q1 2016$167,000
-14.4%
70,567
-17.3%
0.02%
-4.5%
Q4 2015$195,00085,3300.02%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,034,949$1,553,0002.72%
Third Security, LLC 13,238,268$10,095,0000.54%
MSD Partners, L.P. 4,118,402$3,141,0000.16%
SABBY MANAGEMENT, LLC 3,031,953$2,312,0000.13%
Alyeska Investment Group, L.P. 10,000,000$7,626,0000.06%
BARD ASSOCIATES INC 87,999$67,0000.03%
Alyeska Investment Group, L.P. 4,586,592$3,498,0000.03%
FRANKLIN STREET ADVISORS INC /NC 126,000$96,0000.02%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 1,000,000$763,000,0000.02%
HAMILTON LANE ADVISORS LLC 23,855$18,0000.01%
View complete list of SYNTHETIC BIOLOGICS INC shareholders